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The development of a fluorescent-based sensor by combining quantum dots (QDs) with molecularly-
imprinted technology (MIP), intensively optimized to generate exceptional operating features is presented. 
This sensor is designed to target human interleukin-2 (IL-2) in synthetic human serum. IL-2 is a regulatory 
protein released as a triggered response from the immune system towards an inflammation1.  
For this purpose, cadmium telluride (CdTe) QDs are prepared with 3-mercaptopropionic acid (MPA) and 
modified afterwards to produce an IL-2 imprinted polymer. This was made by first incubating IL-2 in PBS 
with aminoethyl methacrylate hydrochloride (AEMH), and polymerizing after with methacrylic acid (MAA) 
and N,N´-methylenebis(acrylamide) (MBA), upon initiation with tetramethylethylenediamine  (TEMED) and 
ammonium persulfate (APS). The template was after removed under optimized conditions.  
 
Scheme 1: (A) Bulk imprinting strategy for the preparation of the conjugated-QDs; (B) Surface imprinting 
strategy for the preparation of the conjugated-QDs. 
 
 
During IL-2 rebinding, the fluorescence intensity of CdTe-MPA QDs is quenched in a concentration 
dependent manner (Scheme 1). Optimal fluorescence signals yielded a linear response versus logarithm 
of IL-2 concentration from 35 fg/mL to 39 pg/mL, in a 1000-fold diluted synthetic human serum. The limit of 
detection obtained is 5.91 fg/mL, lying below the concentration levels of clinical interest2. 
Overall, the method presented herein is a demonstration that the combination of MIP and QDs for protein 
detection constitutes a powerful tool in clinical analysis, providing low cost, sensitive and quick responses. 
The same concept may be further extended to other proteins of interest. 
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